Literature DB >> 22825333

Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications.

Li-Ju Chang1, Alan Eastman.   

Abstract

DNA damage induces the canonical p53 pathway including elevation of p21 (waf1) resulting in arrest of cell cycle progression. This can protect cells from subsequent Chk1 inhibition. Some p53 wild-type cancer cells such as HCT116 and U2OS exhibit attenuated p21 (waf1) induction upon DNA damage due to translational inhibition, and are incapable of maintaining arrest upon Chk1 inhibition. The purpose of this study was to determine whether this attenuated p21 (waf1) induction also occurred with the non-DNA damaging agent Nutlin-3 which induces p53 by disrupting binding to its negative regulator MDM2. We find that Nutlin-3 circumvented the attenuated induction of p21 (waf1) protein by increasing its half-life which led to G 1 and G 2 arrest in both cell lines. Interestingly, the p21 (waf1) protein half-life remained short on Nutlin-3 in p53 wild-type MCF10A cells; these cells achieve high p21 (waf1) levels through transcriptional upregulation. Consequently, all three p53 wild-type cells but not p53 mutant MDA-MB-231 cancer cells were protected from subsequent incubation with a combination of DNA damage plus a checkpoint inhibitor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825333      PMCID: PMC3461812          DOI: 10.4161/cbt.21047

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  48 in total

1.  MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.

Authors:  Yetao Jin; Shelya X Zeng; Xiao-Xin Sun; Hunjoo Lee; Christine Blattner; Zhixiong Xiao; Hua Lu
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

Review 2.  Transcriptional control of human p53-regulated genes.

Authors:  Todd Riley; Eduardo Sontag; Patricia Chen; Arnold Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

Review 3.  Targeting checkpoint kinase 1 in cancer therapeutics.

Authors:  Archie N Tse; Richard Carvajal; Gary K Schwartz
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

4.  DNA damage response to the Mdm2 inhibitor nutlin-3.

Authors:  Rajeev Verma; Marc J Rigatti; Glenn S Belinsky; Cassandra A Godman; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

5.  Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest.

Authors:  Aime A Levesque; Andrew A Fanous; Alissa Poh; Alan Eastman
Journal:  Mol Cancer Ther       Date:  2008-02       Impact factor: 6.261

Review 6.  The G(2) DNA damage checkpoint: could this ancient regulator be the Achilles heel of cancer?

Authors:  Karen Kuntz; Matthew J O'Connell
Journal:  Cancer Biol Ther       Date:  2009-08-22       Impact factor: 4.742

Review 7.  Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy.

Authors:  Sanjeev Shangary; Shaomeng Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

8.  Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition.

Authors:  Sanjeev Shangary; Dongguang Qin; Donna McEachern; Meilan Liu; Rebecca S Miller; Su Qiu; Zaneta Nikolovska-Coleska; Ke Ding; Guoping Wang; Jianyong Chen; Denzil Bernard; Jian Zhang; Yipin Lu; Qingyang Gu; Rajal B Shah; Kenneth J Pienta; Xiaolan Ling; Sanmao Kang; Ming Guo; Yi Sun; Dajun Yang; Shaomeng Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

9.  Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibition.

Authors:  Minwoo Nam; Woo Hyung Lee; Eun Ju Bae; Sang Geon Kim
Journal:  Arch Biochem Biophys       Date:  2008-08-09       Impact factor: 4.013

10.  Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells.

Authors:  Scott A Stuart; Jean Y J Wang
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

View more
  8 in total

1.  Fluctuations in p53 Signaling Allow Escape from Cell-Cycle Arrest.

Authors:  José Reyes; Jia-Yun Chen; Jacob Stewart-Ornstein; Kyle W Karhohs; Caroline S Mock; Galit Lahav
Journal:  Mol Cell       Date:  2018-07-26       Impact factor: 17.970

2.  Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity.

Authors:  Kimo C Stine; Elizabeth C Wahl; Lichu Liu; Robert A Skinner; Jaclyn VanderSchilden; Robert C Bunn; Corey O Montgomery; James Aronson; David L Becton; Richard W Nicholas; Christopher J Swearingen; Larry J Suva; Charles K Lumpkin
Journal:  J Orthop Res       Date:  2016-02-26       Impact factor: 3.494

3.  Repressed miR-34a Expression Dictates the Cell Fate to Corneal Endothelium Failure.

Authors:  Junji Hamuro; Kazuko Asada; Morio Ueno; Tomoko Yamashita; Atsushi Mukai; Tomoko Fujita; Eiko Ito; Nao Hiramoto; Munetoyo Toda; Chie Sotozono; Shigeru Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

Review 4.  The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.

Authors:  Ruth Thompson; Alan Eastman
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

5.  Transcriptional activation of p21Waf1 contributes to suppression of HR by p53 in response to replication arrest induced by camptothecin.

Authors:  Larisa Y Romanova; Frederick Mushinski; Alexander L Kovalchuk
Journal:  Oncotarget       Date:  2018-05-22

6.  Correlation of Occupational Exposure to Carcinogenic Polycyclic Aromatic Hydrocarbons (cPAHs) and Blood Levels of p53 and p21 Proteins.

Authors:  Saleh A K Saleh; Heba M Adly; Imad A Aljahdali; Abdullah A Khafagy
Journal:  Biomolecules       Date:  2022-02-05

7.  Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity.

Authors:  Yee-Lin Voon; Munirah Ahmad; Pooi-Fong Wong; Roslina Husaini; Wayne Tiong-Weng Ng; Chee-Onn Leong; David Philip Lane; Alan Soo-Beng Khoo
Journal:  Oncol Rep       Date:  2015-08-05       Impact factor: 3.906

8.  Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair.

Authors:  Corina Penterling; Guido A Drexler; Claudia Böhland; Ramona Stamp; Christina Wilke; Herbert Braselmann; Randolph B Caldwell; Judith Reindl; Stefanie Girst; Christoph Greubel; Christian Siebenwirth; Wael Y Mansour; Kerstin Borgmann; Günther Dollinger; Kristian Unger; Anna A Friedl
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.